After 20 years, Humira – the best selling drug of all time – is finally facing direct competition. Typically, once generic drugs arrive on a market they dominate sales and deliver big savings. But Humira’s competitors, known as biosimilars, aren’t like most other generics.
This week, what makes this prescription drug showdown so unusual – and so important.
Guest: Marta Wosińska, PhD, Visiting Fellow, Brookings Institution
Learn more and read a full transcript on our website.
Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.
Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

The End of Humira’s $200 Billion Drug Monopoly

Tradeoffs is an award-winning nonprofit news organization on a mission to help the folks on Main Street, Wall Street and Capitol Hill have smarter, more honest conversations about health policy.&nbsp;
Founded in 2019 by former Senior Health Care Reporter at Marketplace, Dan Gorenstein, Tradeoffs’ journalism combines data, evidence and storytelling to help people better understand the complicated, costly and often counterintuitive world of health care.
Learn more about us and find transcripts for each episode at https://tradeoffs.org 
 Hosted on Acast. See acast.com/privacy for more information.

News

Science

While stories of private equity firms running amok in health care are easy to find, new research paints a more nuanced picture.
Guests: Ambar La Forgia, PhD, Professor of Management of Organizations, Berkeley Haas School of Business Rachel Werner, MD, PhD, Executive Director, Leonard Davis Institute of Health Economics, University of Pennsylvania Yashaswini Singh, PhD, Professor of Health Services, Policy and Practice, Brown University School of Public Health Atul Gupta, PhD, Professor Health Care Management, Wharton School, University of Pennsylvania 
Learn more and read a full transcript on our website.
Subscribe to our weekly newsletter. Follow us on X, LinkedIn and Youtube.  Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

Is Private Equity Ruining Health Care? It's Complicated.

A major new study throws cold water on a popular approach to relieving medical debt, but leading experts say the research also reveals a promising path forward. 
Guests: Henry Harrell, MD, Physician  Neale Mahoney, PhD, Professor of Economics, Stanford University Allison Sesso, President and CEO, Undue Medical Debt
Learn more and read a full transcript on our website.
Subscribe to our weekly newsletter. Follow us on X, LinkedIn and Youtube.  Email us at info@tradeoffs.org. 
 Hosted on Acast. See acast.com/privacy for more information.

The Hunt for Lasting Fixes to America’s Medical Debt Crisis

One advocate’s vision for the crucial role patients must play in the future of health care AI.
Andrea Downing, President and Co-Founder, The Light Collective
Learn more and read a full transcript on our website.
Subscribe to our weekly newsletter. Follow us on X, LinkedIn and Youtube.  Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

Patients Push to Shape the Future of AI

Some patients’ lives are so complicated by trauma, poverty and other social problems that routine conditions like diabetes and asthma regularly turn into $10,000 hospital visits. America’s health care leaders have spent years trying to help this small but costly group of patients. What have they learned?
Guests: Jeff Brenner, MD, CEO, The Jewish Board Arthur Brown, Client, Camden Coalition Amy Finkelstein, PhD, Professor of Economics, MIT; Co-Scientific Director, J-PAL North America Allison Hamblin, MSPH, President and CEO, Center for Health Care Strategies Paula Lantz, PhD, Professor of Health Policy, University of Michigan Larry Moore, Client, Camden Coalition Kathleen Noonan, JD, President and CEO, Camden Coalition Dottie Scott, Community Health Worker, Camden Coalition Brian Thompson, Housing Coordinator, Camden Coalition Leslie Walker, Senior Producer/Reporter, Tradeoffs
Learn more and read a full transcript on our website.
Subscribe to our weekly newsletter. Follow us on X, LinkedIn and Youtube.  Email us at info@tradeoffs.org. 
 Hosted on Acast. See acast.com/privacy for more information.

How Do You Help Patients Who Show Up in the ER 100 Times a Year?

One doctor debates whether to work for the nation's largest insurance company after it purchased the independent practice she worked for in Oregon. 
Guest: Gwen O'Keefe, MD, Assistant Professor of Medicine, Department of Anesthesiology & Perioperative Medicine, OHSU
Learn more and read a full transcript on our website.
Subscribe to our weekly newsletter. Follow us on X, LinkedIn and Youtube.  Email us at info@tradeoffs.org. Hosted on Acast. See acast.com/privacy for more information.

The End of Humira’s $200 Billion Drug Monopoly

Download our free app to listen on your phone